Now Reading: Verlinvest, Mirchandani family raise stakes in Epigamia in $20 mn deal
-
01
Verlinvest, Mirchandani family raise stakes in Epigamia in $20 mn deal
Verlinvest, Mirchandani family raise stakes in Epigamia in $20 mn deal
Verlinvest and the family of late Epigamia founder Rohan Mirchandani have increased their stakes in the dairy and snacking startup through a $20 million secondary transaction, Livemint and Inc42 report. Sauce.vc also…
Verlinvest and the family of late Epigamia founder Rohan Mirchandani have increased their stakes in the dairy and snacking startup through a $20 million secondary transaction, Livemint and Inc42 report. Sauce.vc also entered the cap table. Existing investors DSG Consumer Partners and Deepika Padukone's KA Enterprises were among the sellers. Epigamia itself received no fresh capital.
The deal consolidates ownership among long-term shareholders as the company aims to double business every 24-30 months, Livemint quotes CEO Ritesh Gauba as saying. Inc42 reports the startup posted a net loss of Rs 17.4 crore in FY24, down from Rs 67 crore the prior year, with operating revenue of Rs 173.7 crore. Epigamia targets an annual recurring revenue of Rs 700 crore plus this fiscal year.
Indian Opinion Analysis
Both Livemint and Inc42 report the transaction as straight business news, with no political or ideological slant. Livemint places more emphasis on the strategic vision of the investors and the founders family legacy, while Inc42 focuses on the operational transition after Mirchandani's death and the startups financial turnaround. The coverage uniformly treats the deal as a vote of confidence in Epigamia's growth trajectory. The key figure to watch is whether the startup hits its Rs 1,000 crore ARR target for FY28.
Both Livemint and Inc42 report the transaction as straight business news, with no political or ideological slant. Livemint emphasises the strategic vision of investors and the founders family legacy. Inc42 focuses on the operational transition after Mirchandani's death and the financial turnaround. The coverage uniformly treats the deal as a vote of confidence in Epigamia's growth trajectory. The key figure is whether the startup hits its Rs 1,000 crore ARR target for FY28.
Coverage: 2 sources, 2 neutral
Sources (2): livemint.com (neutral report), inc42.com (neutral report)
This story was synthesised by AI from the 2 sources linked above.
Updated: this story now draws on 2 sources.
